Nicky Kumar Jaiswal,
Priyanka Singh,
Kirti,
Vishal Kumar,
- Assistant Professor, School of Pharmacy, Desh Bhagat University, Mandi, Gobindgarh, Punjab, India
- Student, Department of Dental Sciences, Adesh Institute of Dental Sciences and Research, Adesh University, Bathinda, Punjab, India
- Assistant Professor, Department of Pharmaceutical Sciences, Amritsar Group of Colleges, Amritsar, Punjab, India
- Assistant Professor, School of Pharmacy, Desh Bhagat University, Mandi, Gobindgarh, Punjab, India
Abstract
Aims and objective: The main aim of the study is to know the quality of life in GERD patients and the management of GERD with the help of prescription patterns and patient counseling. Methodology: After receiving approval from Departmental Research Committee AIPBS with the reference no AIPBS/2021/4586/11 on dated 30 September 2021 and also approved from the Ethics Committee of Biomedical and Health Research, Adesh University with the reference no AU/EC/PH/2K22/87, the study was performed at Adesh Hospital, Bathinda. The study was a prospective observational study with a total number of 100 GERD patients and a study duration of 6 months. The data were recorded in the self-structured questionnaire. Result: A total number of 100 GERD patients were studied along with their prescription pattern and quality of life. It was determined that particular classes of drugs were prescribed to the patients with their dose details, and age, health condition, gender, and smoking are the factors that affect the quality of life. Gastroesophageal reflux disease is a chronic condition characterized by the backflow of stomach acid or bile into the oesophagus, causing irritation of the lining. GERD is a condition characterized by the occurrence of uncomfortable symptoms and discomfort caused by the backflow of stomach contents. GERD, or gastroesophageal reflux disease, is a common condition affecting the upper gastrointestinal tract. It is estimated that one-third of the population suffers from GERD, with around 10 million cases occurring annually in India. In Western countries, a weekly occurrence of GERD symptoms is reported by 10% to 20% of the population. The diagnosis of GERD is established by evaluating the patient’s clinical history and anamnesis, which involves identifying the specific symptoms, their duration, intensity, frequency, triggers, and factors that provide relief. It is also important to assess the progression of symptoms over time and their impact on the patient’s quality of life. Commonly reported symptoms include heartburn and acid regurgitation.
Keywords: Gastroesophageal, acid reflux, heartburn, esophageal syndrome, extra esophageal syndrome.
[This article belongs to Research & Reviews: A Journal of Pharmacology (rrjop)]
Nicky Kumar Jaiswal, Priyanka Singh, Kirti, Vishal Kumar. A Prospective Observational Study of Prescription and Quality of Life: Gastroesophageal Reflux Disease in Territory Care Hospital. Research & Reviews: A Journal of Pharmacology. 2024; 14(03):14-22.
Nicky Kumar Jaiswal, Priyanka Singh, Kirti, Vishal Kumar. A Prospective Observational Study of Prescription and Quality of Life: Gastroesophageal Reflux Disease in Territory Care Hospital. Research & Reviews: A Journal of Pharmacology. 2024; 14(03):14-22. Available from: https://journals.stmjournals.com/rrjop/article=2024/view=175908
References
1. Wang YK, Hsu WH, Wang SSW, Lu CY, Kuo FC, Su YC, Yang SF, Chen CY, Wu DC, Kuo CH. Current pharmacological management of gastroesophageal reflux disease. Gastroenterol Res Pract. 2013;2013(1):983653. doi:10.1155/2013/983653.
2. Badillo R, Francis D. Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther. 2014;5(3):105–112. doi:10.4292/wjgpt.v5.i3.105.
3. Henry MA. Diagnosis and management of gastroesophageal reflux disease. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 2014;27(3):210–215. doi:10.1590/S0102-67202014000300013.
4. Tutuian R, Castell DO. Management of gastroesophageal reflux disease. Am J Med Sci. 2003;326(5):309–318. doi:10.1097/00000441-200311000-00007.
5. Al-Zahrani SA, Mohamed MZA, Mohammed A, Al-Harbi NM, Al-Qatari BM, Alatwi SA, Asiri AM. Gastroesophageal reflux disease and heartburn among the general population of Saudi Arabia. Int J Med Dev Ctries. 2019;3(11):933–940. doi:10.24911/IJMDC.51-1567426442.
6. Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, Gangarosa LM, Thiny MT, Stizenberg K, Morgan DR, Ringel Y, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterol. 2012;143(5):1179–1187. doi:10.1053/j.gastro.2012.08.002.
7. Butt AK, Hashemy I. Risk factors and prescription patterns of gastroesophageal reflux disease: HEAL study in Pakistan. J Pak Med Assoc. 2014;64(7):751–757.
8. Abrahão-Junior LJ, Lemme EMO. Manifestações extra-esofágicas da DRGE. J Bras Med. 2012; 100(5):17–21.
9. Gyawali CP, Fass R. Management of gastroesophageal reflux disease. Gastroenterol. 2018;154(2):302–318. doi:10.1053/j.gastro.2017.07.049.
10. Heidelbaugh JJ, Nostrant TT, Kim C, Van Harrison R. Management of gastroesophageal reflux disease. Am Fam Physician. 2003;68(7):1311–1319.
11. El-Serag HB. Time trends of gastroesophageal reflux disease: A systematic review. Clinical Gastroenterol Hepatol. 2007;5(1):17–26. doi:10.1016/j.cgh.2006.09.016.
12. Katzka DA, Kahrilas PJ. Advances in the diagnosis and management of gastroesophageal reflux disease. BMJ. 2020;371. doi:10.1136/bmj.m3786.
13. Velanovich V. Comparison of generic (SF-36) vs. disease-specific (GERDHRQL) quality-of-life scales for gastroesophageal reflux disease. J Gastrointest Surg. 1998;2(2):141–145. doi:10.1016/S1091-255X(98)80004-8.
14. El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: A systematic review. Gut. 2014;63:871–880. doi:10.1136/gutjnl-2012-304269.
15. Andrade FJC, et al. Qualidade de vida do paciente submetido à cirurgia videolaparoscópica para tratamento para doença do refluxo gastroesofagico. ABCD Arq Bras Cir Dig. 2012;25(3):154–160.
16. Chua YC, Aziz Q. Perception of gastro-oesophageal reflux. Best Pract Res Clin Gastroenterol. 2010;24(6):883–891. doi:10.1016/j.bpg.2010.10.003.
17. Esubi JU, Olojede SO, Lawal SK, Medubi LJ, Adekoya AJ, Dauda FF, Olusegun AP, Osinubi AA. Comparative studies on safety of glimepiride and glipizide on renal microarchitecture and oxidative stress markers of pregnant streptozotocin-induced diabetic wistar rats. J Pharm Pharmacol Res. 2019;3(1):3–18.
18. Arivan R, Deepanjali S. Prevalence and risk factors of gastro-esophageal reflux disease among undergraduate medical students from a southern Indian medical school: a cross-sectional study. BMC Res Notes. 2018;11:1–5. doi:10.1186/s13104-018-3569-1.
19. Alrashed AA, Aljammaz KI, Pathan A, Mandili AA, Almatrafi SA, Almotire MH, Bahkali SM. Prevalence and risk factors of gastroesophageal reflux disease among Shaqra University students, Saudi Arabia. J Family Med Prim Care. 2019;8(2):462–467. doi:10.4103/jfmpc.jfmpc_443_18.
20. Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018;67(3):430–440. doi:10.1136/gutjnl-2016- 313589.
21. Singh S, Sharma AN, Murad MH, Buttar NS, El-Serag HB, Katzka DA, Iyer PG. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(11):1399–1412.e7. doi:10.1016/j.cgh.2013.05.009.
22. Spantideas N, Drosou E, Bougea A, Assimakopoulos D. Gastroesophageal reflux disease symptoms in the Greek general population: prevalence and risk factors. Clin Exp Gastroenterol. 2016;9:143–149. doi:10.2147/CEG.S103485.
23. Awadalla NJ. Personal, academic and stress correlates of gastroesophageal reflux disease among college students in southwestern Saudi Arabia: A cross-section study. Annals Med Surg. 2019;47:61–65. doi:10.1016/j.amsu.2019.10.009.
Research & Reviews: A Journal of Pharmacology
| Volume | 14 |
| Issue | 03 |
| Received | 20/08/2024 |
| Accepted | 12/09/2024 |
| Published | 27/09/2024 |